Morgan Stanley’s iSpecimen ISPC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-10
Closed -$11.4K 7660
2023
Q2
$11.4K Hold
10
﹤0.01% 6772
2023
Q1
$10.7K Hold
10
﹤0.01% 6865
2022
Q4
$11K Hold
10
﹤0.01% 6895
2022
Q3
$13K Buy
10
+4
+67% +$7.16K ﹤0.01% 6983
2022
Q2
$11K Hold
6
﹤0.01% 7183
2022
Q1
$27K Buy
+6
New +$23.5K ﹤0.01% 7010
2021
Q4
Hold
0
8035

Other funds holding ISPC

Morgan Stanley's ISPC Position: Q3 2023 in Review

Morgan Stanley sold out of iSpecimen (ISPC) in Q3 2023, closing a stake of 10 shares — an estimated $11.4K sold.

Morgan Stanley first reported a position in ISPC in Q1 2022 and held it in 6 quarters. The position peaked at $27K in Q1 2022. 10 funds tracked by Wall St. Rank hold ISPC as of Q3 2023.

  • Morgan Stanley reported no remaining iSpecimen position as of Q3 2023 after selling out during the quarter.
  • Morgan Stanley sold 10 iSpecimen shares in Q3 2023, an estimated $11.4K.
  • Morgan Stanley first reported a position in iSpecimen in Q1 2022 and held it in 6 quarters.
  • Morgan Stanley's iSpecimen position peaked at $27K in Q1 2022.
  • 10 funds tracked by Wall St. Rank held iSpecimen as of Q3 2023.

Based on Morgan Stanley's 13F filing for Q3 2023, filed 15 Nov 2023.